- Tytuł :
- Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
- Autorzy :
- Źródło :
- In Annals of Oncology February 2021 32(2):208-217
-
Czasopismo naukowe